Syntest DS Drug Interactions
Currently displaying 202 drugs known to have a moderate interaction with Syntest DS (esterified estrogens / methyltestosterone).
Moderate interactions with Syntest DS (esterified estrogens / methyltestosterone)
Note: Showing generic names only.
A
- abametapir topical
- acarbose
- acetohexamide
- adagrasib
- albiglutide
- alogliptin
- aminoglutethimide
- amobarbital
- apalutamide
- aprepitant
- asciminib
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- avacopan
B
- bedaquiline
- belzutifan
- berotralstat
- betamethasone
- bexagliflozin
- bexarotene
- black cohosh
- bosentan
- brentuximab
- brigatinib
- budesonide
- butabarbital
- butalbital
C
- C1 esterase inhibitor (human)
- calaspargase pegol
- calcipotriene topical
- calcitriol topical
- canagliflozin
- cannabidiol
- carbamazepine
- cenobamate
- chenodeoxycholic acid
- chloramphenicol
- chlorpropamide
- cholestyramine
- clofarabine
- clotrimazole
- colestipol
- conestat alfa
- conivaptan
- corticorelin
- corticotropin
- cortisone
- cosyntropin
- cyclosporine
D
- dabrafenib
- daclizumab
- dapagliflozin
- darunavir
- deflazacort
- dehydroepiandrosterone
- dexamethasone
- diltiazem
- divalproex sodium
- dulaglutide
- duvelisib
E
- echinacea
- efavirenz
- elafibranor
- elagolix
- empagliflozin
- encorafenib
- enzalutamide
- epirubicin
- ertugliflozin
- erythromycin
- eslicarbazepine
- etranacogene dezaparvovec
- exenatide
F
- felbamate
- fidanacogene elaparvovec
- fluconazole
- fludrocortisone
- fluvoxamine
- fosaprepitant
- fosphenytoin
- fostamatinib
G
H
I
- idelalisib
- imatinib
- insulin
- insulin aspart
- insulin aspart protamine
- insulin degludec
- insulin detemir
- insulin glargine
- insulin glulisine
- insulin inhalation, rapid acting
- insulin isophane
- insulin lispro
- insulin lispro protamine
- insulin regular
- insulin zinc
- insulin zinc extended
- interferon beta-1a
- interferon beta-1b
- isavuconazonium
- isoniazid
- itraconazole
- ivosidenib
L
- lamotrigine
- lapatinib
- larotrectinib
- lefamulin
- lenacapavir
- letermovir
- levothyroxine
- levothyroxine / liothyronine
- linagliptin
- liothyronine
- liotrix
- liraglutide
- lixisenatide
- lonapegsomatropin
- lorlatinib
M
- mavacamten
- melatonin
- mephobarbital
- metformin
- methotrexate
- methylprednisolone
- metyrapone
- mibefradil
- miconazole
- miglitol
- mitotane
- mobocertinib
N
O
P
- pegaspargase
- peginterferon beta-1a
- pentobarbital
- phenobarbital
- phenylbutazone
- phenytoin
- pioglitazone
- pirtobrutinib
- posaconazole
- pramlintide
- prednisolone
- prednisone
- primidone
R
S
- saquinavir
- saxagliptin
- secobarbital
- selpercatinib
- semaglutide
- sitagliptin
- somapacitan-beco
- somatrem
- somatrogon
- somatropin
- sotagliflozin
- sotorasib
- st. john's wort
- succinylcholine
- sulfinpyrazone
T
- tazemetostat
- tecovirimat
- thioguanine
- thyroid desiccated
- tipranavir
- tirzepatide
- tolazamide
- tolbutamide
- tovorafenib
- trabectedin
- triamcinolone
- triamcinolone ophthalmic
- trofinetide
- troglitazone
- tucatinib
V
Syntest DS alcohol/food interactions
There are 4 alcohol/food interactions with Syntest DS (esterified estrogens / methyltestosterone).
Syntest DS disease interactions
There are 27 disease interactions with Syntest DS (esterified estrogens / methyltestosterone) which include:
- carcinoma (male)
- fluid retention
- hypercalcemia in breast cancer
- hyperlipoproteinemia
- liver disease
- polycythemia
- suppression of clotting factors
- abnormal vaginal bleeding
- carcinomas (estrogenic)
- hypercalcemia in breast cancer
- hypertension
- thromboembolism/cardiovascular
- hepatic neoplasms
- diabetes
- hypercalcemia
- angioedema
- gallbladder disease
- hypercalcemia
- hyperlipidemia
- liver disease
- melasma
- depression
- fluid retention
- glucose intolerance
- retinal thrombosis
- thyroid function tests
- thyroid function tests
More about Syntest DS (esterified estrogens / methyltestosterone)
- Syntest DS consumer information
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: sex hormone combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.